View in EDS PDF Full Text

Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients.

Saved in:
Bibliographic Details
Title: Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients.
Authors: Tohda, Y.1, Fujimura, M.2, Taniguchi, H.3, Takagi, K.4, Igarashi, T.5, Yasuhara, H.6, Takahashi, K.7, Nakajima, S.1
Source: Clinical & Experimental Allergy. Aug2002, Vol. 32 Issue 8, p1180-1186. 7p.
Database: Environment Complete
Description
ISSN:09547894
DOI:10.1046/j.1365-2745.2002.01440.x